PRODH induces, in vitro and in vivo, non-small cell lung cancer (NSCLC) cells toward EMT, proliferation and migration, which are blocked by depletion of PRODH (46) (Table 1). The gene discussed is PRODH; the disease is non-small cell lung carcinoma.